好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

What’s All the FUS? An Unusual Case of aFTLD-U
Aging, Dementia, and Behavioral Neurology
Behavioral and Cognitive Neurology Posters (7:00 AM-5:00 PM)
013
To describe an unusual presentation of pathologically-validated atypical frontotemporal lobar degeneration with ubiquitin inclusions (aFTLD-U), a subtype of FLTD- fused in sarcoma (FLTD-FUS).
Frontotemporal dementias are most frequently associated with tau or TDP-43 pathology at autopsy.  The majority of remaining cases will have FUS pathology at autopsy and are typically associated with young-onset behavioral variant presentations.
NA

A 56 year-old man originally presented to memory clinic for one year of gradually progressively decreased speech production, increased impulsivity, and difficulty navigating in a car. At that time, his exam was notable for expressive aphasia, difficulty with Luria hand motions and a shuffling gait.  MRI of the brain initially showed asymmetric left temporal-lobe atrophy. FDG-PET showed decreased uptake in the basal ganglia with symmetric cortical uptake.  A neuropsychiatric evaluation showed mild impairments in attention and working memory with more prominent impairments in memory, language, and visuospatial function. A diagnosis of frontotemporal dementia was rendered.  Over the next two years he developed anarthria, right arm rigidity with dystonic posturing, apraxia, dysphagia, and balance impairments. The clinical diagnosis was revised to corticobasal syndrome.  The patient passed away three years into his illness at age 58.

The fixed brain weighed 1088g.  Frontal horn dilation with caudate and putaminal atrophy was noted. Neuron loss and gliosis was noted in the frontal lobes, hippocampus, and substantia nigra.  Tau (PHF-1) amyloid-beta, phosphorylated alpha-synuclein, and TDP-43 immunohistochemistry did not show any pathologic inclusions. Immunohistochemistry for ubiquitin and FUS showed dentate granule cells with both oval cytoplasmic inclusions and curvilinear intranuclear inclusions most consistent with aFTLD-U.

We present a case of pathologically validated aFTLD-U.  Unusual features of this case include the older age of onset, precipitous decline, and a prominent motor corticobasal syndrome. These features should be added to the growing appreciation of the expanded phenotypes associated with aFTLD-U pathology.
Authors/Disclosures
David G. Coughlin, MD (University of California San Diego)
PRESENTER
The institution of Dr. Coughlin has received research support from 好色先生. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
No disclosure on file
Douglas Galasko, MD (Dept. of Neurosciences, UCSD) Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for vTv Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMed Central.
Anne E. Hiniker, MD (University of California, San Francisco) Dr. Hiniker has nothing to disclose.